Dr Gail Tsang
/content/dam/asset-migration/headshots/au-doctor-headshots/AU_Oncology_Headshot_GA_Dr%20Gail%20Tsang.jpg

Dr Gail Tsang

Dr Gail Tsang
BHB, MBChB, FRANZCR, Radiation Oncologist

I feel humbled by the strength and resilience demonstrated in my patients, so I strive to do my best to improve their cancer treatment outcomes

Languages spoken

English, Cantonese, Mandarin

Overview

Centres

Wesley Medical Centre (Oncology)
Wesley Medical Centre (Oncology)
-27.476494536119898, 152.99746445565626
/au/our-centres/wesley-hospital
Chermside (Oncology)
Chermside (Oncology)
-27.381837593738126, 153.02949042694252
/au/our-centres/chermside

Specialises in

Blood cancer
Condition
Condition/Cancer
Condition/Cancer/Blood Cancer
Breast cancer
Condition
Condition/Cancer
Condition/Cancer/Breast Cancer
Gastrointestinal cancer
Condition
Condition/Cancer
Condition/Cancer/Gastrointestinal Cancer
Genitourinary cancer
Condition
Condition/Cancer
Condition/Cancer/Genitourinary Cancer
Lung cancer
Condition
Condition/Cancer
Condition/Cancer/Lung Cancer
Prostate cancer
Condition
Condition/Cancer
Condition/Cancer/Prostate Cancer
Skin cancer
Condition
Condition/Cancer
Condition/Cancer/Skin Cancer

Treatments

Brachytherapy
Service
Service/Cancer
Service/Cancer/Radiation Oncology
Service/Cancer/Radiation Oncology/Brachytherapy
DCISionRT®
Service
Service/Cancer
Service/Cancer/Radiation Oncology
Service/Cancer/Radiation Oncology/DCISionRT
External beam radiation therapy
Service
Service/Cancer
Service/Cancer/Radiation Oncology
Service/Cancer/Radiation Oncology/External Beam Radiation Therapy
Intensity-modulated radiation therapy (IMRT)
Service
Service/Cancer
Service/Cancer/Radiation Oncology
Service/Cancer/Radiation Oncology/Intensity Modulated Radiation Therapy
Radiation therapy
Service
Service/Cancer
Service/Cancer/Radiation Oncology
Service/Cancer/Radiation Oncology/Radiation Therapy
Stereotactic ablative/body radiation therapy (SABR/SBRT)
Service
Service/Cancer
Service/Cancer/Radiation Oncology
Service/Cancer/Radiation Oncology/Stereotactic Body Radiation Therapy
Volumetric modulated arc therapy (VMAT)
Service
Service/Cancer
Service/Cancer/Radiation Oncology
Service/Cancer/Radiation Oncology/Volumetric modulated arc therapy (VMAT)

Special clinical interests in prostate, brachytherapy, breast, urological, haematological, gastrointestinal, lung cancer, skin cancer and stereotactic cranial and body radiotherapy.

After obtaining Bachelor of Human Biology, Bachelor of Medicine and Bachelor of Surgery, Dr Tsang undertook radiation oncology training and was awarded Fellowship of Royal Australia and New Zealand College of Radiologists.

Dr Tsang has a special interest in breast cancer and a subspecialty interest in prostate brachytherapy, having completed a clinical fellowship in prostate brachytherapy at Sunnybrook Hospital, Toronto, Canada in 2009.

Dr Tsang is accredited for high dose rate and low dose rate prostate brachytherapy at the Brisbane practice.

As an adjunct Professor at Bond University, Dr Tsang participates in undergraduate teaching. She also teaches radiation oncology registrars.

Dr Tsang embraces multidisciplinary team (MDT) meetings to ensure best management for patients through collaboration with different specialties. She actively participates in MDT’s for breast, urological, haematological, lung, gastrointestinal, skin cancer and palliative care and chairs the Wesley Lymphoma meeting.

She is a member of the research committee at the Brisbane practice.

Research interests

  • Breast cancer and oncology research interest

Awards

Dr Tsang was awarded the New Zealand Breast Cancer Foundation research grant of $50,000 in 2005

Professional memberships

  • RANZCR
  • TROG
  • ABG
  • AGITG
  • ASBD

Publications

  • All delays before radiotherapy risk progression of Merkel cell carcinoma. Tsang G, O'Brien P, Robertson R, Hamilton C, Wratten C, Denham J. Australas Radiol. 2004 Sep;48(3):371-5.
  • Health-related quality of life after single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for prostate cancer. Morton GC, Loblaw DA, Chung H, Tsang G, Sankreacha R, Deabreu A, Zhang L, Mamedov A, Cheung P, Batchelar D, Danjoux C, Szumacher E. Int J Radiat Oncol Biol Phys. 2011 Aug 1;80(5):1299-305
  • The use of 68Ga-PET/CT PSMA to determine patterns of disease for biochemically recurrent prostate cancer following primary radiotherapy. Raveenthiran S, Yaxley J, Gianduzzo T, Kua B, McEwan L, Wong D, Tsang G, MacKean J. Prostate Cancer Prostatic Dis. 2019 Sep;22(3):385-390